A study to compare the efficacy of sarivadi kashaya and parpatadi kashaya as gudavarti(suppository) in jwara santapa(pyrexia) in children

Randomised comparative clinical study to evaluate the efficacy of sarivadi kashaya and parpatadi kashaya as gudavarti in jwara santapa with special reference to pyrexia in children - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070206

Enrollment

Registered

2024-07-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with pyrexia with an axillary temperature ranging from 99.80°F to 103.0°F (low to moderate pyrexia). Subjects in whom parents are willing to sign the written consent form will be included.

Exclusion criteria

Exclusion criteria: Subjects who present with high-grade fever and subjects with a history of febrile seizures, epilepsy, or meningitis.

Design outcomes

Primary

Measure	Time frame
Significant decrease in Jwara santapa (pyrexia) assessed based on GRASP fever chart.Timepoint: At 0-30 minutes,60 minutes,120minutes and 180 minutes after administration of gudavarti.	—

Secondary

Measure	Time frame
Generation of in - depth analysed data on the different aspect of the disease- Jwara & generation of data on possible unexpected drug reactions which might occur during the study duration. Timepoint: 3 hours	—

Countries

India

Contacts

Public ContactDr Parvathy B Geethakumar

Sri Sri College of Ayurvedic Science and Research, Bangalore

drsharvarideshpande@icloud.com9901059707

Outcome results